Recent Security Class Actions

Veru Inc. Common Stock (NASDAQ: VERU)

Company Name:Veru Inc. Common Stock
Stock Symbol:NASDAQ: VERU
Class Period Start:05/11/2022
Class Period End (inclusive):11/09/2022
Filing Deadline:02/03/2023

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the data from the VERU-111 Phase 3 trial and the Company's interactions with the FDA. Specifically, the Complaint alleges Veru misled its shareholders to believe that the data from the Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application ("NDA") without any further studies and that VERU's filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.